1. Home
  2. LWLG vs LAB Comparison

LWLG vs LAB Comparison

Compare LWLG & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$4.61

Market Cap

578.6M

Sector

Industrials

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$1.58

Market Cap

488.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWLG
LAB
Founded
1991
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
578.6M
488.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
LWLG
LAB
Price
$4.61
$1.58
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$1.35
AVG Volume (30 Days)
2.7M
1.9M
Earning Date
11-14-2025
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$100,605.00
$169,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.77
52 Week Low
$0.79
$0.92
52 Week High
$6.26
$2.14

Technical Indicators

Market Signals
Indicator
LWLG
LAB
Relative Strength Index (RSI) N/A 58.84
Support Level N/A $1.46
Resistance Level N/A $1.66
Average True Range (ATR) 0.00 0.09
MACD 0.00 0.02
Stochastic Oscillator 0.00 80.23

Price Performance

Historical Comparison
LWLG
LAB

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: